FDA Clears Spinal Cord Stimulator for Diabetic Neuropathy FDA Clears Spinal Cord Stimulator for Diabetic Neuropathy

The Food and Drug Administration has approved Abbott ' s Proclaim XR spinal cord stimulation system for the treatment of diabetic peripheral neuropathy, the company announced.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Neurology & Neurosurgery News Alert Source Type: news